OGN Stock: Organon & Co. Stock Price, Analysis & Insights
Get live OGN stock price $13.40, comprehensive Organon & Co. stock analysis, charts, news, and expert forecast. Real-time OGN stock data and investment insights.
Loading chart data...
Organon & Co. (OGN) Overview
Organon & Co. (OGN) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, OGN trades at $13.40 with a market capitalization of 3.52B . Over the past 52 weeks, OGN has traded between $5.69 and $13.48 , with the current price positioned at approximately 99% of this range . The stock currently trade...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 3.52B
- Current price: $13.40
- 52-week range: $5.69 - $13.48
- P/E ratio: 14.41
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments,...
Company Information
- CEO
- Joseph T. Morrissey Jr.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 10000
Contact Information
- Website
- https://www.organon.com
- Address
- 30 Hudson Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 14.4)
✓ Higher growth potential with elevated volatility (Beta: 1.54)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Organon & Co. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Organon & Co.
- ⚠Investors should consider how Organon & Co. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
3.52B
P/E Ratio (TTM)
14.41
Beta
1.54
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare OGN with peer companies:
- Price
- $4.22
- Market cap
- 1.32B
- Price
- $15.78
- Market cap
- 2.03B
- Price
- $21.64
- Market cap
- 2.12B
- Price
- $42.18
- Market cap
- 2.67B
- Price
- $35.04
- Market cap
- 2.03B
- Price
- $23.59
- Market cap
- 1.94B
- Price
- $4.64
- Market cap
- 1.61B
- Price
- $31.54
- Market cap
- 1.28B
- Price
- $16.61
- Market cap
- 2.06B
- Price
- $5.15
- Market cap
- 615.36M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.